Literature DB >> 16083875

Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study.

Kim Nielsen1, Henrik Vorum, Per Fagerholm, Karin Birkenkamp-Demtröder, Bent Honoré, Niels Ehlers, Torben F Orntoft.   

Abstract

The purpose of this study is to identify corneal proteins differentially expressed between keratoconus and normal epithelial samples. Proteins from the corneal epithelium were isolated from 6 keratoconus and 6 myopia patients (controls) and separated by 2D-gel electrophoresis. Six % and 12% SDS-PAGE gels were used to separate low and high molecular weight proteins. Gels were silver stained and protein spots were defined by Melanie II software. The proteins that were most altered in expression comparing keratoconus and controls were extracted, trypsin-digested, and identified by mass spectroscopy. Approximately 200-500 protein spots were detected on each gel. Nineteen spots were identified as differentially expressed between keratoconus and reference epithelium including cytokeratin 3 (< 7.8 fold), gelsolin (1.6 fold), S100A4 (1.9 fold), and enolase 1 (0.72 fold). Another identified protein found at very high levels was cytokeratin 12. Gelsolin, cytokeratin 3, and cytokeratin 12 have previously been described to be involved in other corneal diseases. Three proteins, gelsolin, alpha enolase, and S100A4 were identified to be differentially expressed in keratoconus compared to reference epithelium and thus may be involved in the pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083875     DOI: 10.1016/j.exer.2005.06.009

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  28 in total

1.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

2.  Changes in tear protein profile in keratoconus disease.

Authors:  A Acera; E Vecino; I Rodríguez-Agirretxe; K Aloria; J M Arizmendi; C Morales; J A Durán
Journal:  Eye (Lond)       Date:  2011-06-24       Impact factor: 3.775

Review 3.  The Human Eye Proteome Project: perspectives on an emerging proteome.

Authors:  Richard D Semba; Jan J Enghild; Vidya Venkatraman; Thomas F Dyrlund; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-08       Impact factor: 3.984

Review 4.  The Human Eye Proteome Project: Updates on an Emerging Proteome.

Authors:  Meleha T Ahmad; Pingbo Zhang; Craig Dufresne; Luigi Ferrucci; Richard D Semba
Journal:  Proteomics       Date:  2018-03       Impact factor: 3.984

5.  Tear metabolite changes in keratoconus.

Authors:  D Karamichos; J D Zieske; H Sejersen; A Sarker-Nag; John M Asara; J Hjortdal
Journal:  Exp Eye Res       Date:  2015-01-09       Impact factor: 3.467

6.  S100A proteins in the pathogenesis of experimental corneal neovascularization.

Authors:  Changyou Li; Feng Zhang; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-10-31       Impact factor: 2.367

7.  Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Bent Honoré; Henrik Vorum; Nakul Mandal; Steffen Heegaard; Jan Ulrik Prause
Journal:  Biol Proced Online       Date:  2009-12-24       Impact factor: 3.244

Review 8.  S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?

Authors:  Mikael Schneider; Jakob L Hansen; Søren P Sheikh
Journal:  J Mol Med (Berl)       Date:  2008-03-06       Impact factor: 4.599

9.  Evaluation of differentially expressed genes identified in keratoconus.

Authors:  Ji-Eun Lee; Boo Sup Oum; Hee Young Choi; Seung Uk Lee; Jong Soo Lee
Journal:  Mol Vis       Date:  2009-11-28       Impact factor: 2.367

10.  Differential Gene Transcription of Extracellular Matrix Components in Response to In Vivo Corneal Crosslinking (CXL) in Rabbit Corneas.

Authors:  Sabine Kling; Arthur Hammer; Emilio A Torres Netto; Farhad Hafezi
Journal:  Transl Vis Sci Technol       Date:  2017-12-12       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.